F

Fujian Aonong Biological Technology Group Incorporation Ltd
SSE:603363

Watchlist Manager
Fujian Aonong Biological Technology Group Incorporation Ltd
SSE:603363
Watchlist
Price: 4.33 CNY -3.13% Market Closed
Market Cap: ¥11.3B

Income Statement

Earnings Waterfall
Fujian Aonong Biological Technology Group Incorporation Ltd

Income Statement
Fujian Aonong Biological Technology Group Incorporation Ltd

Rotate your device to view
Income Statement
Currency: CNY
Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Revenue
Interest Expense
0
10
38
0
0
29
69
56
76
84
92
107
126
163
180
243
310
359
428
494
522
529
524
484
465
468
568
541
534
530
651
578
0
0
Revenue
5 088
N/A
4 960
-3%
4 903
-1%
5 137
+5%
5 376
+5%
5 675
+6%
5 762
+2%
5 746
0%
5 736
0%
5 794
+1%
5 788
0%
6 197
+7%
7 165
+16%
8 860
+24%
11 517
+30%
13 663
+19%
15 649
+15%
17 504
+12%
18 038
+3%
18 299
+1%
18 636
+2%
20 119
+8%
21 613
+7%
22 276
+3%
22 862
+3%
21 387
-6%
19 458
-9%
17 048
-12%
14 047
-18%
11 206
-20%
8 763
-22%
8 138
-7%
8 064
-1%
8 173
+1%
Gross Profit
Cost of Revenue
(4 204)
(4 056)
(3 978)
(4 236)
(4 537)
(4 855)
(4 979)
(4 978)
(4 968)
(5 059)
(5 051)
(5 247)
(5 905)
(7 268)
(9 531)
(11 488)
(13 818)
(16 307)
(18 209)
(18 781)
(19 268)
(20 041)
(20 956)
(21 188)
(22 024)
(21 317)
(20 767)
(18 149)
(14 742)
(11 545)
(8 367)
(7 577)
(7 470)
(7 614)
Gross Profit
884
N/A
904
+2%
924
+2%
901
-2%
839
-7%
820
-2%
782
-5%
768
-2%
768
+0%
735
-4%
737
+0%
950
+29%
1 260
+33%
1 592
+26%
1 986
+25%
2 175
+10%
1 831
-16%
1 197
-35%
(170)
N/A
(481)
-182%
(632)
-31%
77
N/A
657
+750%
1 088
+66%
838
-23%
71
-92%
(1 309)
N/A
(1 101)
+16%
(695)
+37%
(339)
+51%
396
N/A
561
+42%
594
+6%
559
-6%
Operating Income
Operating Expenses
(716)
(713)
(741)
(725)
(719)
(708)
(685)
(662)
(637)
(582)
(562)
(537)
(589)
(666)
(813)
(906)
(1 155)
(1 205)
(1 121)
(1 567)
(1 431)
(1 528)
(1 288)
(1 588)
(1 646)
(1 569)
(1 295)
(2 074)
(2 004)
(2 033)
(1 252)
(1 206)
(1 055)
(901)
Selling, General & Administrative
(659)
(630)
(621)
(612)
(606)
(595)
(564)
(506)
(522)
(489)
(473)
(500)
(549)
(634)
(739)
(859)
(922)
(951)
(948)
(1 030)
(1 064)
(1 150)
(1 051)
(1 154)
(1 149)
(1 130)
(963)
(1 178)
(1 194)
(1 200)
(820)
(1 086)
(937)
(780)
Research & Development
0
(26)
(104)
0
0
(56)
(106)
(80)
(102)
(86)
(70)
(63)
(58)
(61)
(63)
(74)
(88)
(98)
(111)
(126)
(134)
(148)
(157)
(176)
(172)
(162)
(144)
(116)
(97)
(76)
(52)
(50)
(46)
(48)
Depreciation & Amortization
0
0
(22)
0
0
0
(22)
0
0
0
(29)
0
0
0
(43)
0
0
0
(88)
0
0
0
(145)
0
0
0
(228)
0
0
0
(451)
0
0
0
Other Operating Expenses
(58)
(57)
7
(113)
(112)
(58)
7
(76)
(13)
(7)
10
27
18
30
33
26
(145)
(156)
27
(412)
(233)
(229)
65
(258)
(325)
(278)
40
(779)
(712)
(757)
71
(70)
(72)
(72)
Operating Income
168
N/A
191
+14%
184
-4%
176
-4%
121
-31%
112
-7%
98
-12%
105
+8%
132
+25%
153
+16%
175
+14%
414
+136%
671
+62%
926
+38%
1 174
+27%
1 269
+8%
675
-47%
(8)
N/A
(1 291)
-15 909%
(2 049)
-59%
(2 063)
-1%
(1 450)
+30%
(631)
+56%
(500)
+21%
(808)
-62%
(1 498)
-85%
(2 605)
-74%
(3 175)
-22%
(2 699)
+15%
(2 372)
+12%
(856)
+64%
(645)
+25%
(461)
+28%
(342)
+26%
Pre-Tax Income
Interest Income Expense
(33)
(35)
(35)
(45)
(50)
(59)
(66)
(74)
(82)
(87)
(96)
(116)
(122)
(154)
(200)
(244)
(320)
(374)
(487)
(560)
(597)
(612)
(639)
(589)
(565)
(557)
(583)
(601)
(598)
(596)
(632)
1 688
1 896
2 048
Non-Reccuring Items
(2)
(2)
0
(0)
0
0
(10)
0
(1)
(1)
(3)
0
(1)
(1)
(8)
(4)
(4)
(4)
(29)
(3)
(2)
(3)
(41)
4
6
1
(463)
30
35
65
1 906
(23)
(32)
(45)
Gain/Loss on Disposition of Assets
0
0
0
0
0
0
(3)
0
0
0
0
0
0
0
(12)
0
0
0
(23)
0
0
0
(12)
0
0
0
(11)
0
0
0
(41)
0
0
0
Total Other Income
5
3
0
(2)
(3)
(2)
1
(0)
4
4
2
(4)
17
17
17
8
(11)
3
9
(12)
(8)
(10)
28
39
40
36
(20)
(62)
(94)
(153)
(292)
(332)
(297)
(244)
Pre-Tax Income
138
N/A
157
+14%
149
-5%
129
-13%
68
-47%
51
-25%
20
-61%
31
+56%
52
+67%
69
+32%
78
+13%
294
+277%
565
+92%
788
+39%
971
+23%
1 029
+6%
340
-67%
(383)
N/A
(1 822)
-376%
(2 623)
-44%
(2 670)
-2%
(2 075)
+22%
(1 295)
+38%
(1 045)
+19%
(1 327)
-27%
(2 019)
-52%
(3 682)
-82%
(3 807)
-3%
(3 356)
+12%
(3 055)
+9%
84
N/A
688
+714%
1 106
+61%
1 416
+28%
Net Income
Tax Provision
(18)
(24)
(27)
(25)
(20)
(18)
(10)
(5)
(2)
5
23
31
50
48
23
19
1
(3)
(29)
(19)
13
34
69
54
25
12
(87)
(83)
(87)
(133)
(21)
(30)
(15)
39
Income from Continuing Operations
120
134
122
105
49
34
10
26
50
73
100
325
615
836
994
1 048
341
(385)
(1 851)
(2 642)
(2 657)
(2 041)
(1 226)
(991)
(1 302)
(2 007)
(3 769)
(3 891)
(3 443)
(3 188)
63
658
1 091
1 455
Income to Minority Interest
(16)
(15)
(14)
(6)
12
16
20
8
(15)
(34)
(71)
(162)
(269)
(345)
(421)
(464)
(268)
(47)
331
609
623
451
187
124
131
251
118
128
61
8
516
432
389
357
Net Income (Common)
104
N/A
119
+14%
108
-9%
99
-9%
61
-38%
49
-19%
30
-39%
33
+11%
35
+4%
39
+12%
29
-25%
163
+462%
346
+112%
491
+42%
573
+17%
584
+2%
72
-88%
(432)
N/A
(1 520)
-252%
(2 034)
-34%
(2 034)
0%
(1 590)
+22%
(1 038)
+35%
(867)
+16%
(1 172)
-35%
(1 756)
-50%
(3 651)
-108%
(3 763)
-3%
(3 382)
+10%
(3 180)
+6%
579
N/A
1 090
+88%
1 480
+36%
1 812
+22%
EPS (Diluted)
0.23
N/A
0.26
+13%
0.22
-15%
0.17
-23%
0.12
-29%
0.09
-25%
0.05
-44%
0.06
+20%
0.07
+17%
0.07
N/A
0.05
-29%
0.29
+480%
0.61
+110%
0.72
+18%
0.91
+26%
0.79
-13%
0.1
-87%
-0.64
N/A
-2.34
-266%
-3.11
-33%
-2.62
+16%
-1.9
+27%
-1.34
+29%
-1.01
+25%
-1.32
-31%
-2.04
-55%
-4.21
-106%
-4.32
-3%
-3.89
+10%
-3.65
+6%
0.67
N/A
0.41
-39%
0.58
+41%
0.68
+17%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett